U.S. CRO Clinlogix has expanded into Asia, opening offices in Singapore and Tokyo to tap the growing market for clinical research in the region. The company, headquartered in Pennsylvania, already has operations in Europe and South America and is expanding into Asia to provide "proper training, oversight and further develop our partnerships with clinical sites in these markets, which is vital to ensuring both the regulatory and clinical development success of our clients' emerging medical technologies." More
> PPD is expanding its Preclarus data-management product to support central lab operations. Item
> TransCelerate BioPharma, a nonprofit supported by the world's largest drugmakers, has crafted a new subsidiary focused on improving the efficiency of preclinical research. News